Our OmniViz Pro software will be of great value to companies in the life sciences and chemical industries. Other collaborations will be announced in the near future. Battelle will be releasing OmniViz Pro Version 1.0 on a selected basis in April and to the broader marketplace shortly thereafter. Maiden indicated that a CEO will be hired in the near future to lead the OmniViz, Inc. spinout. Unfortunately, data analysis tools have not kept pace with these advances.
Companies often receive the same data at the same time.
The winners will be those companies that can quickly transform raw data into sources of high value information - such as drug development targets and leads. Battelle, headquartered in Columbus, Ohio, focuses on technology development and commercialization and product development. With 7,500 employees at more than 60 locations, Battelle develops technologies and products for industry and government. All rights reserved.